You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 70677-0074


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 70677-0074

Drug Name NDC Price/Unit ($) Unit Date
SM FEXOFENADINE HCL 180 MG TAB 70677-0074-01 0.22930 EACH 2025-01-22
SM FEXOFENADINE HCL 180 MG TAB 70677-0074-02 0.22930 EACH 2025-01-22
SM FEXOFENADINE HCL 180 MG TAB 70677-0074-03 0.22930 EACH 2025-01-22
SM FEXOFENADINE HCL 180 MG TAB 70677-0074-01 0.23198 EACH 2024-12-18
SM FEXOFENADINE HCL 180 MG TAB 70677-0074-03 0.23198 EACH 2024-12-18
SM FEXOFENADINE HCL 180 MG TAB 70677-0074-02 0.23198 EACH 2024-12-18
SM FEXOFENADINE HCL 180 MG TAB 70677-0074-03 0.20794 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 70677-0074

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Trends in the Pharmaceutical Industry: Implications for Drug Pricing and Projections

Introduction to the Pharmaceutical Market

The pharmaceutical industry is at a pivotal moment, driven by technological advancements, changing consumer behaviors, and evolving regulatory landscapes. Understanding these trends is crucial for analyzing market dynamics and making informed price projections.

Current State of the Pharmaceutical Industry

The pharmaceutical industry is forecasted to grow significantly, with several key trends shaping its future. Here are some of the most impactful:

Role of AI in Drug Development

AI is revolutionizing the drug development process, reducing the time and cost associated with bringing new drugs to market. By 2024, AI has cut the development time from 10 years to just 4 years, with costs dropping substantially[2].

Gene Editing and Personalized Medicine

Technologies like CRISPR gene editing are transitioning from lab theories to real treatments, enabling personalized medicine tailored to individual genetic codes. This shift is expected to become more standard by 2025[2].

Big Data and Blockchain

Big data systems are processing millions of patient records to identify patterns that humans cannot, while blockchain technology is enhancing the transparency of drug supply chains[2].

Market Drivers and Restraints

High Cost of Prescription Drugs

One of the primary drivers of the over-the-counter (OTC) drugs market is the high cost of prescription drugs. This has led to a significant shift towards OTC drugs, as consumers seek more affordable alternatives. For instance, a study by the Kaiser Family Foundation indicated that nearly one in three US individuals does not take medication as prescribed due to high costs[3].

Increasing Approval of OTC Drugs

The FDA has approved several new OTC drugs recently, such as Futura Medical's Eroxon and Harm Reduction Therapeutics' RiVive, which are expected to boost the market growth[3].

Stringent Regulatory Policies

Despite the growth drivers, stringent regulatory policies are a significant restraint. These policies can slow down the approval process and hamper market growth[3].

Market Segmentation and Competitive Landscape

Product Types

The OTC drugs market is segmented into various product types, including cough, cold, and flu products, analgesics, dermatology products, gastrointestinal products, and more. Dermatology products, for example, are expected to witness healthy growth due to new approvals and launches[3].

Distribution Channels

The market is also segmented by distribution channels, including retail pharmacies, online pharmacies, and hospital pharmacies. Online pharmacies are becoming increasingly popular, contributing to the market's growth[3].

Competitive Landscape

The US OTC drugs market is fragmented, with several key players such as Johnson and Johnson, Novartis AG, Bayer AG, Sanofi SA, and Pfizer. These companies hold significant market shares and are known for their innovative products and strategies[3].

AI and Health Tech Trends

Adoption of AI in Clinical Development

By 2025, the adoption of AI in standard operations for clinical development is expected to double, with more companies relying on external data to train internal data science models. This includes the use of large language models (LLMs) to retrieve information and produce reports[5].

Expert AI Applications

Expert AI applications, such as those addressing the probability of technical and regulatory success (PTRS), will gain more prominence. This is due to the industry's need to trust in more sophisticated AI models beyond generic generative AI[5].

Price Projections and Market Growth

Market Size and Growth

The US OTC drugs market is estimated to be around $42.80 billion in 2024 and is expected to reach $53 billion by 2029, growing at a CAGR of 4.40% during the forecast period[3].

Impact of Regulatory Changes

Regulatory changes and approvals will significantly influence price projections. For instance, the approval of new OTC drugs and the shift towards more affordable alternatives will drive market growth and potentially stabilize or reduce prices[3].

Specific Analysis for NDC 70677-0074

While the provided sources do not specifically mention the NDC 70677-0074, the broader trends and market analysis can be applied to understand its potential pricing and market dynamics.

  • Market Positioning: If the drug falls under a category with high demand, such as dermatology or analgesics, it is likely to benefit from the overall market growth.
  • Regulatory Environment: The drug's pricing will be influenced by regulatory policies and the cost of development. Given the trend of increasing OTC drug approvals, there might be opportunities for this drug to be positioned competitively.
  • Technological Advancements: The use of AI and big data could enhance the drug's development and marketing, potentially reducing costs and improving its market positioning.

Key Takeaways

  • The pharmaceutical industry is undergoing significant changes driven by AI, gene editing, and big data.
  • The high cost of prescription drugs is driving a shift towards OTC drugs.
  • Regulatory policies and approvals are crucial for market growth and pricing.
  • AI adoption in clinical development is expected to double by 2025.
  • The US OTC drugs market is projected to grow at a CAGR of 4.40% from 2024 to 2029.

FAQs

1. How is AI impacting the pharmaceutical industry? AI is accelerating drug development by analyzing vast datasets, predicting molecular structure changes, and reducing development time and costs.

2. What are the key drivers of the OTC drugs market? The high cost of prescription drugs and increasing approvals of OTC drugs are primary drivers of the OTC drugs market.

3. How will blockchain technology affect the pharmaceutical industry? Blockchain technology is enhancing the transparency of drug supply chains, ensuring more secure and traceable distribution.

4. What role will personalized medicine play in 2025? Personalized medicine, tailored to individual genetic codes, is expected to become more standard by 2025, driven by advancements in gene editing technologies like CRISPR.

5. How will the adoption of AI in clinical development change by 2025? The adoption of AI in standard operations for clinical development is expected to double by 2025, with a greater reliance on external data and large language models.

Sources

  1. FDA.report - NDC 70677-1024
  2. Laboratorios Rubio - The Future of Pharma: 2025's Key Trends To Know
  3. GlobeNewswire - U.S. OTC Drugs Market Forecast Report 2024-2029
  4. YouTube - NDC Directory (March 2015)
  5. Intelligencia.ai - 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.